Keywords: b-ms, ixempra, increases, pfs, triple, negative, bc

B-MS' Ixempra increases PFS in triple negative BC

Article | 22 December 2008

Print This

US drug major Bristol-Myers Squibb says new study data show that Ixempra (ixabepilone) plus capecitabine resulted in a significant increase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in